SEC Form 4 · accession 0001400482-16-000230
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · M??????
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lukas Scheibler
Officer — EVP of Research & Development
Period of report
Sep 17, 2016
Accepted (ET)
Sep 20, 2016 · 12:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001400482
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 17, 2016 | M | 2,663 | $0.00 | A | 2,663 | D | |
| Common StockF1,F3 | Sep 20, 2016 | S | 2,663 | $9.5312 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F4 | — | Sep 17, 2016 | M | 2,663 | D | — | — | Common Stock | 2,663 | 93,222 | D |
Explanation of responses
- F1The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192900).
- F2Each restricted stock unit (RSU) represents a contingent right to receive (1) share of the issuer's common stock upon settlement. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
- F3The shares were sold at a price of 971.8077 Japanese Yen. The U.S. per share price reflects the average of the buy and sell Japanese Yen-to-U.S. Dollar exchange rates on the transaction date divided by the number of shares sold. These shares were sold in multiple transactions at prices ranging from 970 to 972 Japanese Yen, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F4On August 17, 2015, the reporting person was granted 127,847 RSUs, four year vesting period, with 25% of the RSUs vesting on August 17, 2016, and the remainder vesting thereafter on a monthly pro-rata basis, such that 100% of the RSUs are vested on August 17, 2019, subject to the reporting person's continuing employment through the applicable vesting date.